Robert Azelby

Officer, Juno Therapeutics, Inc.

Companies

Tango Therapeutics (United States)Board member Jun 23, 2026 to now¹
Autolus TherapeuticsBoard member Mar 18, 2026 to now²
Terns Pharmaceuticals, Inc.Board member Feb 24, 2025 to now³
Cardinal HealthBoard member Mar 1, 2024 to now⁴
ADC Therapeutics SABoard member Jan 2, 2024 to now⁵
CHINOOK THERAPEUTICS, INC.Board member Apr 12, 2023 to Aug 11, 2023⁶
Climb Bio, Inc.President Jan 31, 2022 to Nov 2, 2022⁷
Climb Bio, Inc.Board member Aug 9, 2021 to Nov 2, 2022⁸
Climb Bio, Inc.Chief executive officer Aug 9, 2021 to Nov 2, 2022⁸
Clovis OncologyBoard member Oct 12, 2018 to Jun 11, 2021⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTango Therapeutics (United States), Board member
2
SEC EDGARAutolus Therapeutics, Board member
3
SEC EDGARTerns Pharmaceuticals, Inc., Board member
4
SEC EDGARCardinal Health, Board member
5
SEC EDGARADC Therapeutics SA, Board member
6
SEC EDGARCHINOOK THERAPEUTICS, INC., Board member
7
SEC EDGARClimb Bio, Inc., President
8
SEC EDGARClimb Bio, Inc., Board member
9
SEC EDGARClovis Oncology, Board member